Morphine Sulfate
NDC Package 27808-084-02
Package Information
Morphine Sulfate is oral Solution 2 mg/mL is indicated for the management of:adults with pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.pediatric patients 2 years of age and older with pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.Morphine Sulfate Oral Solution 20 mg/mL is indicated for use in opioid-tolerant adult patients who require higher doses of opioids for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.Limitations of Use:Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.2)], reserve opioid analgesics, including Morphine Sulfate Oral Solution, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Marketed by Cranbury Pharmaceuticals, Llc, this product is identified by NDC 27808-084 and is authorized under FDA application ANDA203518.
Identification & Billing
- RxCUI: 892589 - morphine sulfate 10 MG in 5 mL Oral Solution
- RxCUI: 892589 - morphine sulfate 2 MG/ML Oral Solution
- RxCUI: 892589 - morphine sulfate 10 MG per 5 ML Oral Solution
- RxCUI: 892589 - MS 2 MG/ML Oral Solution
- RxCUI: 892625 - morphine sulfate 20 MG in 1 mL Concentrate for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 27808 - Cranbury Pharmaceuticals, Llc
- 27808-084 - Morphine Sulfate
- 27808-084-02 - 500 mL in 1 BOTTLE
- 27808-084 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (27808-084). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 27808-084-02 identifies a specific commercial package of 500 ml in 1 bottle of Morphine Sulfate, labeled by Cranbury Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cranbury Pharmaceuticals, Llc on September 21, 2015. The current certification is valid through September 10, 2021.
How is this Cranbury Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 27808008402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.